Group chat messages released, Tesla’s stock comeback, new UTI drug & more
CNN 5 Things
00:00
New Antibiotic Approval to Combat Recurring UTIs
This chapter explores the approval of Blue Jepa, a new oral antibiotic targeting recurrent urinary tract infections in women. It also touches on the rising resistance of bacteria to current medications and previews future podcast topics.
Play episode from 04:12
Transcript
